Research and Markets: Methicillin-Resistant Staphylococcus Aureus (MRSA) Therapeutics – Pipeline Assessment and Market Forecasts to 2019 – Business Wire

MRSA is a common bacterial, hospital-acquired infection which occurs in patients with weakened immune systems, and is resistant to beta-lactam antibiotics such as methicillin, amoxicillin, penicillin and oxacillin. MRSA can cause a broad variety of …

Leave a Reply

Your email address will not be published.